These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 22991302

  • 1. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D, Schmitt M, Dyckhoff G, Benner A, Pawlita M, Bosch FX.
    Cancer Res; 2012 Oct 01; 72(19):4993-5003. PubMed ID: 22991302
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM, Snijders PJ, Beekzada D, Braakhuis BJ, Brink A, Heideman DA, Hesselink AT, Witte BI, Bloemena E, Baatenburg-De Jong RJ, Leemans CR, Brakenhoff RH.
    Int J Cancer; 2014 May 15; 134(10):2366-72. PubMed ID: 24249631
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR, Janus JR, Olsen SM, Wang VW, Garcia JJ, Graham RP, Moore EJ, Olsen KD, Kasperbauer JL, Price DL, Berres M, Halling G, Smith DI.
    Laryngoscope; 2012 Dec 15; 122(12):2707-11. PubMed ID: 22961429
    [Abstract] [Full Text] [Related]

  • 4. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M, Jaworska M, Pigłowski W, Goraj-Zając A, Woźniak G, Lange D.
    Pol J Pathol; 2010 Dec 15; 61(3):133-9. PubMed ID: 21225495
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M, Broglie MA, Förbs D, Stoeckli SJ, Jochum W.
    J Otolaryngol Head Neck Surg; 2018 Sep 06; 47(1):53. PubMed ID: 30189895
    [Abstract] [Full Text] [Related]

  • 6. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J, Nekvindova J, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Vosmikova H, Vosmik M, Neskudlova T, Cermakova E, Hacova M, Sobande FA, Ryska A.
    Neoplasma; 2012 Sep 06; 59(4):398-408. PubMed ID: 22489695
    [Abstract] [Full Text] [Related]

  • 7. Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway.
    Holzinger D, Flechtenmacher C, Henfling N, Kaden I, Grabe N, Lahrmann B, Schmitt M, Hess J, Pawlita M, Bosch FX.
    Int J Cancer; 2013 Sep 15; 133(6):1389-99. PubMed ID: 23457055
    [Abstract] [Full Text] [Related]

  • 8. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL, Psyrri A.
    J Clin Oncol; 2006 Feb 10; 24(5):736-47. PubMed ID: 16401683
    [Abstract] [Full Text] [Related]

  • 9. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM, Yu Z, Kountourakis P, Sasaki C, Haffty BG, Kowalski D, Merkley MA, Rimm DL, Camp RL, Psyrri A.
    Otolaryngol Head Neck Surg; 2009 Sep 10; 141(3):382-9. PubMed ID: 19716018
    [Abstract] [Full Text] [Related]

  • 10. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS.
    Am J Surg Pathol; 2011 Sep 10; 35(9):1343-50. PubMed ID: 21836494
    [Abstract] [Full Text] [Related]

  • 11. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.
    Cancer Res; 2012 Oct 01; 72(19):5004-13. PubMed ID: 22991304
    [Abstract] [Full Text] [Related]

  • 12. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW.
    Clin Cancer Res; 2010 Apr 01; 16(7):2138-46. PubMed ID: 20233885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials.
    Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML.
    Am J Surg Pathol; 2012 Jul 01; 36(7):945-54. PubMed ID: 22743284
    [Abstract] [Full Text] [Related]

  • 15. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J, Wald T, Kuhnt T, Gradistanac T, Kolb M, Dietz A, Wiegand S, Wichmann G.
    Cancer; 2020 Jan 01; 126(9):1856-1872. PubMed ID: 32032442
    [Abstract] [Full Text] [Related]

  • 16. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ, Gültekin SE, Straetmans JM, Haesevoets A, Peutz-Kootstra CJ, Huebbers CU, Dienes HP, Wieland U, Ramaekers FC, Kremer B, Speel EJ, Klussmann JP.
    Int J Cancer; 2014 May 01; 134(9):2108-17. PubMed ID: 24127203
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K.
    Cancer Med; 2013 Dec 01; 2(6):933-41. PubMed ID: 24403267
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
    Mirghani H, Moreau F, Lefèvre M, Tam C, Périé S, Soussan P, St Guily JL.
    Arch Otolaryngol Head Neck Surg; 2011 Sep 01; 137(9):910-4. PubMed ID: 21930979
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS, van Velthuysen ML, van den Brekel MW, Jordanova ES, Melief CJ, Balm AJ.
    Int J Cancer; 2012 Apr 15; 130(8):1806-12. PubMed ID: 21607949
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Prigge ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M.
    Int J Cancer; 2017 Mar 01; 140(5):1186-1198. PubMed ID: 27859245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.